BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37116145)

  • 21. Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.
    Sam SS; Thomas V; Reddy KS; Surianarayanan G; Chandrasekaran A
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):945-51. PubMed ID: 20012094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians.
    Sakai K; Loza E; Roig GV; Nozaki R; Asai T; Ikoma T; Tsuchiya Y; Kiyohara C; Yamamoto M; Nakamura K
    Asian Pac J Cancer Prev; 2016; 17(2):781-4. PubMed ID: 26925680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
    Singh SA; Ghosh SK
    Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study.
    Lavender NA; Benford ML; VanCleave TT; Brock GN; Kittles RA; Moore JH; Hein DW; Kidd LC
    BMC Cancer; 2009 Nov; 9():397. PubMed ID: 19917083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer.
    Sreelekha TT; Ramadas K; Pandey M; Thomas G; Nalinakumari KR; Pillai MR
    Oral Oncol; 2001 Oct; 37(7):593-8. PubMed ID: 11564581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of nasopharyngeal cancer risk with genetic polymorphisms of drug-metabolizing enzyme genes GSTM1, GSTT1 and CYP1A1 (rs4646903 variant), in tobacco addicted patients of Pashtun ethnicity of Khyber Pakhtunkhwa Province of Pakistan.
    Zakiullah -; Saeed M; Javed N; Khuda F; Ovais M
    Pak J Pharm Sci; 2019 Sep; 32(5):2107-2116. PubMed ID: 31813877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.
    Murata M; Watanabe M; Yamanaka M; Kubota Y; Ito H; Nagao M; Katoh T; Kamataki T; Kawamura J; Yatani R; Shiraishi T
    Cancer Lett; 2001 Apr; 165(2):171-7. PubMed ID: 11275366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an.
    Wang AH; Sun CS; Li LS; Huang JY; Chen QS
    World J Gastroenterol; 2002 Feb; 8(1):49-53. PubMed ID: 11833070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
    Przygodzki RM; Bennett WP; Guinee DG; Khan MA; Freedman A; Shields PG; Travis WD; Jett JR; Tazelaar H; Pairolero P; Trastek V; Liotta LA; Harris CC; Caporaso NE
    Pharmacogenetics; 1998 Dec; 8(6):503-11. PubMed ID: 9918134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese.
    Darazy M; Balbaa M; Mugharbil A; Saeed H; Sidani H; Abdel-Razzak Z
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):423-9. PubMed ID: 21385088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.
    Casson AG; Zheng Z; Chiasson D; MacDonald K; Riddell DC; Guernsey JR; Guernsey DL; McLaughlin J
    Cancer Detect Prev; 2003; 27(2):139-46. PubMed ID: 12670526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
    González A; Ramírez V; Cuenca P; Sierra R
    Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Using MSR model to analyze the impact of gene-gene interaction with related to the genetic polymorphism of metabolism enzymes on the risk of breast cancer].
    Li JY; Long QM; Tao P; Hu R; Li H; Lei FM; Zhou WD; Li SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):780-3, 787. PubMed ID: 19024313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.
    Honma HN; De Capitani EM; Perroud MW; Barbeiro AS; Toro IF; Costa DB; Lima CS; Zambon L
    Lung Cancer; 2008 Aug; 61(2):152-62. PubMed ID: 18280004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias.
    López-Cima MF; Alvarez-Avellón SM; Pascual T; Fernández-Somoano A; Tardón A
    BMC Cancer; 2012 Sep; 12():433. PubMed ID: 23013535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
    Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians.
    Gaspar PA; Hutz MH; Salzano FM; Hill K; Hurtado AM; Petzl-Erler ML; Tsuneto LT; Weimer TA
    Am J Phys Anthropol; 2002 Nov; 119(3):249-56. PubMed ID: 12365037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.